Cargando…
Effectiveness and safety of the PlasmaJet® Device in advanced stage ovarian carcinoma: a systematic review
About 80 % of all women affected by ovarian cancer present with advanced stage disease at the time of diagnosis. Achieving complete cytoreduction is complicated when many small tumor spots are found. Yet, complete cytoreduction is the most important determinant of survival. Application of a thermal...
Autores principales: | Nieuwenhuyzen-de Boer, Gatske M., van der Kooy, Jacoba, van Beekhuizen, Heleen J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6668166/ https://www.ncbi.nlm.nih.gov/pubmed/31362769 http://dx.doi.org/10.1186/s13048-019-0545-x |
Ejemplares similares
-
Cytoreductive Surgery with the PlasmaJet Improved Quality-of-Life for Advanced Stage Ovarian Cancer Patients
por: Nieuwenhuyzen-de Boer, Gatske M., et al.
Publicado: (2023) -
ASO Author Reflections: The PlasmaJet(®) Device Contributes to an Increase in the Number of Complete Cytoreductive Surgeries for Ovarian Cancer Patients
por: Nieuwenhuyzen-de Boer, G. M., et al.
Publicado: (2022) -
Evaluation of effectiveness of the PlasmaJet surgical device in the treatment of advanced stage ovarian cancer (PlaComOv-study): study protocol of a randomized controlled trial in the Netherlands
por: Nieuwenhuyzen-de Boer, G. M., et al.
Publicado: (2019) -
Adjuvant Use of PlasmaJet Device During Cytoreductive Surgery for Advanced-Stage Ovarian Cancer: Results of the PlaComOv-study, a Randomized Controlled Trial in The Netherlands
por: Nieuwenhuyzen-de Boer, G. M., et al.
Publicado: (2022) -
The effects of neutral argon plasma versus electrocoagulation on tissue in advanced-stage ovarian cancer: a case series
por: Nieuwenhuyzen-de Boer, Gatske M., et al.
Publicado: (2022)